Upgrade to SI Premium - Free Trial

Relay Therapeutics (RLAY)

19.04 +0.03 (0.16%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Form 4 Relay Therapeutics, Inc. For: Aug 26 Filed by: Rahmer Peter August 28, 2026 4:44 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Aug 25 Filed by: SB INVESTMENT ADVISERS (UK) LTD August 28, 2026 9:02 AM - SEC Filing Form 144 Relay Therapeutics, Inc. Filed by: Rahmer Peter August 26, 2026 4:16 PM - SEC Filing Form 144 Relay Therapeutics, Inc. Filed by: SVF Pauling (Cayman) Ltd August 25, 2026 7:43 PM - SEC Filing Relay Therapeutics (RLAY) PT Raised to $29 at H.C. Wainwright August 20, 2026 6:55 AM - StreetInsider Form 4 Relay Therapeutics, Inc. For: Aug 17 Filed by: Patel Sanjiv August 18, 2026 4:18 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Aug 14 Filed by: Catinazzo Thomas August 18, 2026 4:17 PM - SEC Filing Form SCHEDULE 13G/A Relay Therapeutics, Inc. Filed by: Commodore Capital LP August 14, 2026 4:18 PM - SEC Filing Relay Therapeutics (RLAY) PT Raised to $31 at JPMorgan August 14, 2026 9:04 AM - StreetInsider Form SCHEDULE 13G/A Relay Therapeutics, Inc. Filed by: PERCEPTIVE ADVISORS LLC August 10, 2026 4:00 PM - SEC Filing Relay Therapeutics (RLAY) PT Raised to $26 at Citizens on Zovega Data August 10, 2026 4:12 AM - StreetInsider Form SCHEDULE 13G/A Relay Therapeutics, Inc. Filed by: FMR LLC August 7, 2026 11:20 AM - SEC Filing Relay Therapeutics (RLAY) PT Raised to $30 at Barclays August 7, 2026 4:55 AM - StreetInsider Guggenheim Reiterates Buy Rating on Relay Therapeutics (RLAY) August 7, 2026 2:08 AM - StreetInsider Relay Therapeutics, Inc. (RLAY) Misses Q2 EPS by 2c August 6, 2026 5:49 PM - StreetInsider Form 424B5 Relay Therapeutics, Inc. August 6, 2026 4:44 PM - SEC Filing Form 10-Q Relay Therapeutics, Inc. For: Jun 30 August 6, 2026 4:21 PM - SEC Filing Form 8-K Relay Therapeutics, Inc. For: Aug 06 August 6, 2026 4:16 PM - SEC Filing Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates August 6, 2026 4:05 PM - StreetInsider Form SCHEDULE 13G Relay Therapeutics, Inc. Filed by: FMR LLC August 6, 2026 10:39 AM - SEC Filing Form 144 Relay Therapeutics, Inc. Filed by: Kathiresan Sekar August 4, 2026 4:12 PM - SEC Filing Form 144 Relay Therapeutics, Inc. Filed by: Kathiresan Sekar July 31, 2026 4:06 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jul 28 Filed by: Catinazzo Thomas July 30, 2026 4:14 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jul 28 Filed by: Rahmer Peter July 30, 2026 4:14 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jul 28 Filed by: Bergstrom Donald A July 30, 2026 4:13 PM - SEC Filing Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026 July 30, 2026 4:05 PM - StreetInsider Form 144 Relay Therapeutics, Inc. Filed by: Kathiresan Sekar July 21, 2026 4:11 PM - SEC Filing Relay Therapeutics (RLAY) PT Raised to $31 at Goldman Sachs July 21, 2026 6:38 AM - StreetInsider Form 144 Relay Therapeutics, Inc. Filed by: Kathiresan Sekar July 20, 2026 4:06 PM - SEC Filing Canaccord Starts Relay Therapeutics (RLAY) at Buy July 16, 2026 5:06 AM - StreetInsider Form 4 Relay Therapeutics, Inc. For: Jul 06 Filed by: Bergstrom Donald A July 8, 2026 5:11 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jul 07 Filed by: Patel Sanjiv July 8, 2026 5:08 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jul 06 Filed by: Catinazzo Thomas July 8, 2026 5:07 PM - SEC Filing JPMorgan Starts Relay Therapeutics (RLAY) at Overweight July 8, 2026 3:12 AM - StreetInsider Form 144 Relay Therapeutics, Inc. Filed by: Patel Sanjiv July 7, 2026 4:36 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jun 30 Filed by: Rahmer Peter July 2, 2026 4:13 PM - SEC Filing Form 144 Relay Therapeutics, Inc. Filed by: Rahmer Peter June 30, 2026 4:35 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jun 22 Filed by: Catinazzo Thomas June 24, 2026 4:10 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jun 22 Filed by: Bergstrom Donald A June 24, 2026 4:09 PM - SEC Filing Form 144 Relay Therapeutics, Inc. Filed by: Bergstrom Donald A June 22, 2026 4:57 PM - SEC Filing Form 144 Relay Therapeutics, Inc. Filed by: Catinazzo Thomas June 22, 2026 4:57 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jun 09 Filed by: Mazumdar Claire June 10, 2026 4:30 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jun 09 Filed by: COATS LONNEL June 10, 2026 4:30 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jun 09 Filed by: Dable Habib J June 10, 2026 4:30 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jun 09 Filed by: HILL LINDA A June 10, 2026 4:30 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jun 09 Filed by: INGRAM DOUGLAS S June 10, 2026 4:30 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jun 09 Filed by: Murcko Mark June 10, 2026 4:30 PM - SEC Filing Form 4 Relay Therapeutics, Inc. For: Jun 09 Filed by: Borisy Alexis June 10, 2026 4:30 PM - SEC Filing Nuvation Bio (NUVB) Reiterated at Market Outperform by Citizens Amid Acquisition by GSK June 10, 2026 5:19 AM - StreetInsider Form 8-K Relay Therapeutics, Inc. For: Jun 09 June 9, 2026 4:36 PM - SEC Filing Full Article List